nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—ORM1—Penbutolol—coronary artery disease	0.142	0.3	CbGbCtD
Disopyramide—ORM1—Pitavastatin—coronary artery disease	0.124	0.262	CbGbCtD
Disopyramide—SCN5A—purkinje fiber—coronary artery disease	0.0348	0.276	CbGeAlD
Disopyramide—CYP3A4—Ticagrelor—coronary artery disease	0.0303	0.0641	CbGbCtD
Disopyramide—KCND3—endocardium—coronary artery disease	0.0299	0.237	CbGeAlD
Disopyramide—CYP3A4—Fenofibrate—coronary artery disease	0.027	0.0571	CbGbCtD
Disopyramide—CYP3A4—Gemfibrozil—coronary artery disease	0.0216	0.0456	CbGbCtD
Disopyramide—CYP3A4—Clopidogrel—coronary artery disease	0.0187	0.0396	CbGbCtD
Disopyramide—SCN5A—endocardium—coronary artery disease	0.0179	0.142	CbGeAlD
Disopyramide—CYP3A4—Eplerenone—coronary artery disease	0.0174	0.0368	CbGbCtD
Disopyramide—SCN5A—sinoatrial node—coronary artery disease	0.017	0.135	CbGeAlD
Disopyramide—CYP3A4—Enalapril—coronary artery disease	0.0155	0.0328	CbGbCtD
Disopyramide—CYP3A4—Ezetimibe—coronary artery disease	0.0121	0.0255	CbGbCtD
Disopyramide—CYP3A4—Rosuvastatin—coronary artery disease	0.0121	0.0255	CbGbCtD
Disopyramide—CYP3A4—Simvastatin—coronary artery disease	0.0112	0.0237	CbGbCtD
Disopyramide—CYP3A4—Pravastatin—coronary artery disease	0.011	0.0232	CbGbCtD
Disopyramide—CYP3A4—Lovastatin—coronary artery disease	0.011	0.0232	CbGbCtD
Disopyramide—CYP3A4—Atorvastatin—coronary artery disease	0.00999	0.0211	CbGbCtD
Disopyramide—CYP3A4—Losartan—coronary artery disease	0.00914	0.0193	CbGbCtD
Disopyramide—KCND2—cardiac ventricle—coronary artery disease	0.00288	0.0229	CbGeAlD
Disopyramide—KCND3—cardiac ventricle—coronary artery disease	0.00251	0.0199	CbGeAlD
Disopyramide—KCND3—myocardium—coronary artery disease	0.00236	0.0188	CbGeAlD
Disopyramide—KCND2—heart—coronary artery disease	0.00189	0.015	CbGeAlD
Disopyramide—KCND2—cardiovascular system—coronary artery disease	0.00179	0.0142	CbGeAlD
Disopyramide—KCND3—heart—coronary artery disease	0.00165	0.0131	CbGeAlD
Disopyramide—KCND3—cardiovascular system—coronary artery disease	0.00156	0.0124	CbGeAlD
Disopyramide—SCN5A—cardiac ventricle—coronary artery disease	0.00151	0.012	CbGeAlD
Disopyramide—SCN5A—myocardium—coronary artery disease	0.00142	0.0113	CbGeAlD
Disopyramide—KCND3—cardiac atrium—coronary artery disease	0.00141	0.0112	CbGeAlD
Disopyramide—SCN5A—heart—coronary artery disease	0.000991	0.00786	CbGeAlD
Disopyramide—SCN5A—cardiovascular system—coronary artery disease	0.000935	0.00742	CbGeAlD
Disopyramide—SCN5A—cardiac atrium—coronary artery disease	0.000848	0.00672	CbGeAlD
Disopyramide—CHRM2—heart—coronary artery disease	0.000844	0.00669	CbGeAlD
Disopyramide—CHRM2—cardiovascular system—coronary artery disease	0.000796	0.00631	CbGeAlD
Disopyramide—SCN5A—blood—coronary artery disease	0.000739	0.00587	CbGeAlD
Disopyramide—CHRM1—cardiovascular system—coronary artery disease	0.000725	0.00575	CbGeAlD
Disopyramide—ORM1—blood—coronary artery disease	0.000675	0.00535	CbGeAlD
Disopyramide—SLC22A1—blood—coronary artery disease	0.000618	0.0049	CbGeAlD
Disopyramide—Dextropropoxyphene—OPRD1—coronary artery disease	0.00038	0.397	CrCbGaD
Disopyramide—CYP3A4—blood—coronary artery disease	0.000282	0.00224	CbGeAlD
Disopyramide—Methadone—OPRD1—coronary artery disease	0.000258	0.27	CrCbGaD
Disopyramide—Tolterodine—CYP2C19—coronary artery disease	0.000216	0.225	CrCbGaD
Disopyramide—Paraesthesia—Losartan—coronary artery disease	0.000132	0.000482	CcSEcCtD
Disopyramide—Urticaria—Telmisartan—coronary artery disease	0.000132	0.000481	CcSEcCtD
Disopyramide—Vomiting—Clopidogrel—coronary artery disease	0.000132	0.000481	CcSEcCtD
Disopyramide—Diarrhoea—Simvastatin—coronary artery disease	0.000132	0.000481	CcSEcCtD
Disopyramide—Chest pain—Ramipril—coronary artery disease	0.000131	0.00048	CcSEcCtD
Disopyramide—Fatigue—Furosemide—coronary artery disease	0.000131	0.00048	CcSEcCtD
Disopyramide—Body temperature increased—Telmisartan—coronary artery disease	0.000131	0.000479	CcSEcCtD
Disopyramide—Dyspnoea—Losartan—coronary artery disease	0.000131	0.000479	CcSEcCtD
Disopyramide—Vomiting—Lovastatin—coronary artery disease	0.000131	0.000478	CcSEcCtD
Disopyramide—Somnolence—Losartan—coronary artery disease	0.000131	0.000477	CcSEcCtD
Disopyramide—Dizziness—Eplerenone—coronary artery disease	0.000131	0.000477	CcSEcCtD
Disopyramide—Rash—Clopidogrel—coronary artery disease	0.000131	0.000477	CcSEcCtD
Disopyramide—Dermatitis—Clopidogrel—coronary artery disease	0.00013	0.000476	CcSEcCtD
Disopyramide—Asthenia—Valsartan—coronary artery disease	0.00013	0.000476	CcSEcCtD
Disopyramide—Pain—Furosemide—coronary artery disease	0.00013	0.000476	CcSEcCtD
Disopyramide—Constipation—Furosemide—coronary artery disease	0.00013	0.000476	CcSEcCtD
Disopyramide—Ill-defined disorder—Lisinopril—coronary artery disease	0.00013	0.000475	CcSEcCtD
Disopyramide—Discomfort—Ramipril—coronary artery disease	0.00013	0.000474	CcSEcCtD
Disopyramide—Asthenia—Olmesartan—coronary artery disease	0.00013	0.000474	CcSEcCtD
Disopyramide—Headache—Clopidogrel—coronary artery disease	0.00013	0.000474	CcSEcCtD
Disopyramide—Rash—Lovastatin—coronary artery disease	0.00013	0.000474	CcSEcCtD
Disopyramide—Dermatitis—Lovastatin—coronary artery disease	0.00013	0.000473	CcSEcCtD
Disopyramide—Dyspepsia—Losartan—coronary artery disease	0.000129	0.000472	CcSEcCtD
Disopyramide—Feeling abnormal—Perindopril—coronary artery disease	0.000129	0.000472	CcSEcCtD
Disopyramide—Headache—Lovastatin—coronary artery disease	0.000129	0.000471	CcSEcCtD
Disopyramide—Pruritus—Valsartan—coronary artery disease	0.000129	0.00047	CcSEcCtD
Disopyramide—Dry mouth—Ramipril—coronary artery disease	0.000129	0.00047	CcSEcCtD
Disopyramide—Chest pain—Timolol—coronary artery disease	0.000129	0.000469	CcSEcCtD
Disopyramide—Vomiting—Ezetimibe—coronary artery disease	0.000128	0.000469	CcSEcCtD
Disopyramide—Angioedema—Lisinopril—coronary artery disease	0.000128	0.000467	CcSEcCtD
Disopyramide—Pruritus—Olmesartan—coronary artery disease	0.000128	0.000467	CcSEcCtD
Disopyramide—Decreased appetite—Losartan—coronary artery disease	0.000128	0.000467	CcSEcCtD
Disopyramide—Body temperature increased—Captopril—coronary artery disease	0.000128	0.000466	CcSEcCtD
Disopyramide—Dizziness—Simvastatin—coronary artery disease	0.000127	0.000465	CcSEcCtD
Disopyramide—Rash—Ezetimibe—coronary artery disease	0.000127	0.000465	CcSEcCtD
Disopyramide—Dermatitis—Ezetimibe—coronary artery disease	0.000127	0.000464	CcSEcCtD
Disopyramide—Confusional state—Ramipril—coronary artery disease	0.000127	0.000464	CcSEcCtD
Disopyramide—Discomfort—Timolol—coronary artery disease	0.000127	0.000464	CcSEcCtD
Disopyramide—Asthenia—Niacin—coronary artery disease	0.000127	0.000463	CcSEcCtD
Disopyramide—Fatigue—Losartan—coronary artery disease	0.000127	0.000463	CcSEcCtD
Disopyramide—Headache—Ezetimibe—coronary artery disease	0.000126	0.000462	CcSEcCtD
Disopyramide—Malaise—Lisinopril—coronary artery disease	0.000126	0.000461	CcSEcCtD
Disopyramide—Oedema—Ramipril—coronary artery disease	0.000126	0.00046	CcSEcCtD
Disopyramide—Vertigo—Lisinopril—coronary artery disease	0.000126	0.000459	CcSEcCtD
Disopyramide—Dry mouth—Timolol—coronary artery disease	0.000126	0.000459	CcSEcCtD
Disopyramide—Pain—Losartan—coronary artery disease	0.000126	0.000459	CcSEcCtD
Disopyramide—Constipation—Losartan—coronary artery disease	0.000126	0.000459	CcSEcCtD
Disopyramide—Syncope—Lisinopril—coronary artery disease	0.000126	0.000459	CcSEcCtD
Disopyramide—Vomiting—Eplerenone—coronary artery disease	0.000126	0.000459	CcSEcCtD
Disopyramide—Feeling abnormal—Furosemide—coronary artery disease	0.000126	0.000458	CcSEcCtD
Disopyramide—Nausea—Fenofibrate—coronary artery disease	0.000125	0.000457	CcSEcCtD
Disopyramide—Pruritus—Niacin—coronary artery disease	0.000125	0.000457	CcSEcCtD
Disopyramide—Asthenia—Pravastatin—coronary artery disease	0.000125	0.000456	CcSEcCtD
Disopyramide—Rash—Eplerenone—coronary artery disease	0.000125	0.000455	CcSEcCtD
Disopyramide—Urticaria—Perindopril—coronary artery disease	0.000124	0.000455	CcSEcCtD
Disopyramide—Dermatitis—Eplerenone—coronary artery disease	0.000124	0.000454	CcSEcCtD
Disopyramide—Diarrhoea—Valsartan—coronary artery disease	0.000124	0.000454	CcSEcCtD
Disopyramide—Confusional state—Timolol—coronary artery disease	0.000124	0.000454	CcSEcCtD
Disopyramide—Shock—Ramipril—coronary artery disease	0.000124	0.000453	CcSEcCtD
Disopyramide—Body temperature increased—Perindopril—coronary artery disease	0.000124	0.000452	CcSEcCtD
Disopyramide—Diarrhoea—Olmesartan—coronary artery disease	0.000124	0.000452	CcSEcCtD
Disopyramide—Headache—Eplerenone—coronary artery disease	0.000124	0.000452	CcSEcCtD
Disopyramide—Thrombocytopenia—Ramipril—coronary artery disease	0.000123	0.000451	CcSEcCtD
Disopyramide—Oedema—Timolol—coronary artery disease	0.000123	0.00045	CcSEcCtD
Disopyramide—Pruritus—Pravastatin—coronary artery disease	0.000123	0.000449	CcSEcCtD
Disopyramide—Loss of consciousness—Lisinopril—coronary artery disease	0.000123	0.000449	CcSEcCtD
Disopyramide—Nausea—Clopidogrel—coronary artery disease	0.000123	0.000449	CcSEcCtD
Disopyramide—Skin disorder—Ramipril—coronary artery disease	0.000122	0.000447	CcSEcCtD
Disopyramide—Vomiting—Simvastatin—coronary artery disease	0.000122	0.000447	CcSEcCtD
Disopyramide—Nausea—Lovastatin—coronary artery disease	0.000122	0.000446	CcSEcCtD
Disopyramide—Hyperhidrosis—Ramipril—coronary artery disease	0.000122	0.000445	CcSEcCtD
Disopyramide—Rash—Simvastatin—coronary artery disease	0.000121	0.000443	CcSEcCtD
Disopyramide—Dermatitis—Simvastatin—coronary artery disease	0.000121	0.000443	CcSEcCtD
Disopyramide—Asthenia—Trandolapril—coronary artery disease	0.000121	0.000443	CcSEcCtD
Disopyramide—Shock—Timolol—coronary artery disease	0.000121	0.000443	CcSEcCtD
Disopyramide—Feeling abnormal—Losartan—coronary artery disease	0.000121	0.000442	CcSEcCtD
Disopyramide—Urticaria—Furosemide—coronary artery disease	0.000121	0.000442	CcSEcCtD
Disopyramide—Diarrhoea—Niacin—coronary artery disease	0.000121	0.000441	CcSEcCtD
Disopyramide—Asthenia—Enalapril—coronary artery disease	0.000121	0.000441	CcSEcCtD
Disopyramide—Headache—Simvastatin—coronary artery disease	0.000121	0.00044	CcSEcCtD
Disopyramide—Body temperature increased—Furosemide—coronary artery disease	0.00012	0.00044	CcSEcCtD
Disopyramide—Dizziness—Valsartan—coronary artery disease	0.00012	0.000439	CcSEcCtD
Disopyramide—Anorexia—Ramipril—coronary artery disease	0.00012	0.000439	CcSEcCtD
Disopyramide—Nausea—Ezetimibe—coronary artery disease	0.00012	0.000438	CcSEcCtD
Disopyramide—Skin disorder—Timolol—coronary artery disease	0.00012	0.000437	CcSEcCtD
Disopyramide—Dizziness—Olmesartan—coronary artery disease	0.00012	0.000437	CcSEcCtD
Disopyramide—Pruritus—Trandolapril—coronary artery disease	0.00012	0.000437	CcSEcCtD
Disopyramide—Chest pain—Lisinopril—coronary artery disease	0.000119	0.000435	CcSEcCtD
Disopyramide—Hyperhidrosis—Timolol—coronary artery disease	0.000119	0.000435	CcSEcCtD
Disopyramide—Asthenia—Telmisartan—coronary artery disease	0.000119	0.000435	CcSEcCtD
Disopyramide—Pruritus—Enalapril—coronary artery disease	0.000119	0.000435	CcSEcCtD
Disopyramide—Diarrhoea—Pravastatin—coronary artery disease	0.000119	0.000435	CcSEcCtD
Disopyramide—Discomfort—Lisinopril—coronary artery disease	0.000118	0.00043	CcSEcCtD
Disopyramide—Hypotension—Ramipril—coronary artery disease	0.000118	0.00043	CcSEcCtD
Disopyramide—Anorexia—Timolol—coronary artery disease	0.000117	0.000429	CcSEcCtD
Disopyramide—Pruritus—Telmisartan—coronary artery disease	0.000117	0.000429	CcSEcCtD
Disopyramide—Nausea—Eplerenone—coronary artery disease	0.000117	0.000428	CcSEcCtD
Disopyramide—Dizziness—Niacin—coronary artery disease	0.000117	0.000427	CcSEcCtD
Disopyramide—Urticaria—Losartan—coronary artery disease	0.000117	0.000426	CcSEcCtD
Disopyramide—Dry mouth—Lisinopril—coronary artery disease	0.000117	0.000426	CcSEcCtD
Disopyramide—Body temperature increased—Losartan—coronary artery disease	0.000116	0.000424	CcSEcCtD
Disopyramide—Asthenia—Captopril—coronary artery disease	0.000116	0.000423	CcSEcCtD
Disopyramide—Diarrhoea—Trandolapril—coronary artery disease	0.000116	0.000422	CcSEcCtD
Disopyramide—Vomiting—Valsartan—coronary artery disease	0.000116	0.000422	CcSEcCtD
Disopyramide—Confusional state—Lisinopril—coronary artery disease	0.000115	0.000421	CcSEcCtD
Disopyramide—Diarrhoea—Enalapril—coronary artery disease	0.000115	0.00042	CcSEcCtD
Disopyramide—Hypotension—Timolol—coronary artery disease	0.000115	0.00042	CcSEcCtD
Disopyramide—Dizziness—Pravastatin—coronary artery disease	0.000115	0.00042	CcSEcCtD
Disopyramide—Vomiting—Olmesartan—coronary artery disease	0.000115	0.00042	CcSEcCtD
Disopyramide—Rash—Valsartan—coronary artery disease	0.000115	0.000418	CcSEcCtD
Disopyramide—Dermatitis—Valsartan—coronary artery disease	0.000114	0.000418	CcSEcCtD
Disopyramide—Nausea—Simvastatin—coronary artery disease	0.000114	0.000417	CcSEcCtD
Disopyramide—Oedema—Lisinopril—coronary artery disease	0.000114	0.000417	CcSEcCtD
Disopyramide—Pruritus—Captopril—coronary artery disease	0.000114	0.000417	CcSEcCtD
Disopyramide—Rash—Olmesartan—coronary artery disease	0.000114	0.000416	CcSEcCtD
Disopyramide—Insomnia—Ramipril—coronary artery disease	0.000114	0.000416	CcSEcCtD
Disopyramide—Dermatitis—Olmesartan—coronary artery disease	0.000114	0.000416	CcSEcCtD
Disopyramide—Headache—Valsartan—coronary artery disease	0.000114	0.000416	CcSEcCtD
Disopyramide—Diarrhoea—Telmisartan—coronary artery disease	0.000114	0.000415	CcSEcCtD
Disopyramide—Headache—Olmesartan—coronary artery disease	0.000113	0.000414	CcSEcCtD
Disopyramide—Paraesthesia—Ramipril—coronary artery disease	0.000113	0.000413	CcSEcCtD
Disopyramide—Shock—Lisinopril—coronary artery disease	0.000112	0.000411	CcSEcCtD
Disopyramide—Asthenia—Perindopril—coronary artery disease	0.000112	0.000411	CcSEcCtD
Disopyramide—Dyspnoea—Ramipril—coronary artery disease	0.000112	0.00041	CcSEcCtD
Disopyramide—Vomiting—Niacin—coronary artery disease	0.000112	0.00041	CcSEcCtD
Disopyramide—Somnolence—Ramipril—coronary artery disease	0.000112	0.000409	CcSEcCtD
Disopyramide—Thrombocytopenia—Lisinopril—coronary artery disease	0.000112	0.000409	CcSEcCtD
Disopyramide—Dizziness—Trandolapril—coronary artery disease	0.000112	0.000408	CcSEcCtD
Disopyramide—Insomnia—Timolol—coronary artery disease	0.000111	0.000407	CcSEcCtD
Disopyramide—Rash—Niacin—coronary artery disease	0.000111	0.000407	CcSEcCtD
Disopyramide—Dermatitis—Niacin—coronary artery disease	0.000111	0.000406	CcSEcCtD
Disopyramide—Dizziness—Enalapril—coronary artery disease	0.000111	0.000406	CcSEcCtD
Disopyramide—Skin disorder—Lisinopril—coronary artery disease	0.000111	0.000405	CcSEcCtD
Disopyramide—Dyspepsia—Ramipril—coronary artery disease	0.000111	0.000405	CcSEcCtD
Disopyramide—Pruritus—Perindopril—coronary artery disease	0.000111	0.000405	CcSEcCtD
Disopyramide—Headache—Niacin—coronary artery disease	0.000111	0.000404	CcSEcCtD
Disopyramide—Paraesthesia—Timolol—coronary artery disease	0.000111	0.000404	CcSEcCtD
Disopyramide—Vomiting—Pravastatin—coronary artery disease	0.000111	0.000404	CcSEcCtD
Disopyramide—Hyperhidrosis—Lisinopril—coronary artery disease	0.00011	0.000403	CcSEcCtD
Disopyramide—Diarrhoea—Captopril—coronary artery disease	0.00011	0.000403	CcSEcCtD
Disopyramide—Dyspnoea—Timolol—coronary artery disease	0.00011	0.000401	CcSEcCtD
Disopyramide—Dizziness—Telmisartan—coronary artery disease	0.00011	0.000401	CcSEcCtD
Disopyramide—Rash—Pravastatin—coronary artery disease	0.00011	0.000401	CcSEcCtD
Disopyramide—Dermatitis—Pravastatin—coronary artery disease	0.00011	0.0004	CcSEcCtD
Disopyramide—Decreased appetite—Ramipril—coronary artery disease	0.00011	0.0004	CcSEcCtD
Disopyramide—Somnolence—Timolol—coronary artery disease	0.00011	0.0004	CcSEcCtD
Disopyramide—Asthenia—Furosemide—coronary artery disease	0.000109	0.000399	CcSEcCtD
Disopyramide—Headache—Pravastatin—coronary artery disease	0.000109	0.000398	CcSEcCtD
Disopyramide—Anorexia—Lisinopril—coronary artery disease	0.000109	0.000398	CcSEcCtD
Disopyramide—Fatigue—Ramipril—coronary artery disease	0.000109	0.000397	CcSEcCtD
Disopyramide—Dyspepsia—Timolol—coronary artery disease	0.000108	0.000396	CcSEcCtD
Disopyramide—Nausea—Valsartan—coronary artery disease	0.000108	0.000394	CcSEcCtD
Disopyramide—Pruritus—Furosemide—coronary artery disease	0.000108	0.000394	CcSEcCtD
Disopyramide—Constipation—Ramipril—coronary artery disease	0.000108	0.000394	CcSEcCtD
Disopyramide—Nausea—Olmesartan—coronary artery disease	0.000107	0.000392	CcSEcCtD
Disopyramide—Vomiting—Trandolapril—coronary artery disease	0.000107	0.000392	CcSEcCtD
Disopyramide—Diarrhoea—Perindopril—coronary artery disease	0.000107	0.000392	CcSEcCtD
Disopyramide—Decreased appetite—Timolol—coronary artery disease	0.000107	0.000391	CcSEcCtD
Disopyramide—Vomiting—Enalapril—coronary artery disease	0.000107	0.000391	CcSEcCtD
Disopyramide—Hypotension—Lisinopril—coronary artery disease	0.000107	0.00039	CcSEcCtD
Disopyramide—Dizziness—Captopril—coronary artery disease	0.000107	0.00039	CcSEcCtD
Disopyramide—Rash—Trandolapril—coronary artery disease	0.000107	0.000389	CcSEcCtD
Disopyramide—Dermatitis—Trandolapril—coronary artery disease	0.000106	0.000389	CcSEcCtD
Disopyramide—Fatigue—Timolol—coronary artery disease	0.000106	0.000388	CcSEcCtD
Disopyramide—Rash—Enalapril—coronary artery disease	0.000106	0.000387	CcSEcCtD
Disopyramide—Dermatitis—Enalapril—coronary artery disease	0.000106	0.000387	CcSEcCtD
Disopyramide—Headache—Trandolapril—coronary artery disease	0.000106	0.000387	CcSEcCtD
Disopyramide—Vomiting—Telmisartan—coronary artery disease	0.000106	0.000385	CcSEcCtD
Disopyramide—Asthenia—Losartan—coronary artery disease	0.000105	0.000385	CcSEcCtD
Disopyramide—Headache—Enalapril—coronary artery disease	0.000105	0.000385	CcSEcCtD
Disopyramide—Pain—Timolol—coronary artery disease	0.000105	0.000385	CcSEcCtD
Disopyramide—Nausea—Niacin—coronary artery disease	0.000105	0.000383	CcSEcCtD
Disopyramide—Rash—Telmisartan—coronary artery disease	0.000105	0.000382	CcSEcCtD
Disopyramide—Dermatitis—Telmisartan—coronary artery disease	0.000105	0.000382	CcSEcCtD
Disopyramide—Diarrhoea—Furosemide—coronary artery disease	0.000104	0.000381	CcSEcCtD
Disopyramide—Pruritus—Losartan—coronary artery disease	0.000104	0.00038	CcSEcCtD
Disopyramide—Headache—Telmisartan—coronary artery disease	0.000104	0.00038	CcSEcCtD
Disopyramide—Feeling abnormal—Ramipril—coronary artery disease	0.000104	0.000379	CcSEcCtD
Disopyramide—Dizziness—Perindopril—coronary artery disease	0.000104	0.000378	CcSEcCtD
Disopyramide—Insomnia—Lisinopril—coronary artery disease	0.000103	0.000378	CcSEcCtD
Disopyramide—Nausea—Pravastatin—coronary artery disease	0.000103	0.000377	CcSEcCtD
Disopyramide—Methadone—CYP2C19—coronary artery disease	0.000103	0.108	CrCbGaD
Disopyramide—Paraesthesia—Lisinopril—coronary artery disease	0.000103	0.000375	CcSEcCtD
Disopyramide—Vomiting—Captopril—coronary artery disease	0.000103	0.000375	CcSEcCtD
Disopyramide—Dyspnoea—Lisinopril—coronary artery disease	0.000102	0.000372	CcSEcCtD
Disopyramide—Rash—Captopril—coronary artery disease	0.000102	0.000372	CcSEcCtD
Disopyramide—Dermatitis—Captopril—coronary artery disease	0.000102	0.000371	CcSEcCtD
Disopyramide—Somnolence—Lisinopril—coronary artery disease	0.000102	0.000371	CcSEcCtD
Disopyramide—Feeling abnormal—Timolol—coronary artery disease	0.000102	0.000371	CcSEcCtD
Disopyramide—Headache—Captopril—coronary artery disease	0.000101	0.000369	CcSEcCtD
Disopyramide—Dizziness—Furosemide—coronary artery disease	0.000101	0.000368	CcSEcCtD
Disopyramide—Dyspepsia—Lisinopril—coronary artery disease	0.000101	0.000367	CcSEcCtD
Disopyramide—Diarrhoea—Losartan—coronary artery disease	0.000101	0.000367	CcSEcCtD
Disopyramide—Nausea—Trandolapril—coronary artery disease	0.0001	0.000366	CcSEcCtD
Disopyramide—Urticaria—Ramipril—coronary artery disease	0.0001	0.000366	CcSEcCtD
Disopyramide—Nausea—Enalapril—coronary artery disease	0.0001	0.000365	CcSEcCtD
Disopyramide—Vomiting—Perindopril—coronary artery disease	9.96e-05	0.000364	CcSEcCtD
Disopyramide—Body temperature increased—Ramipril—coronary artery disease	9.96e-05	0.000364	CcSEcCtD
Disopyramide—Decreased appetite—Lisinopril—coronary artery disease	9.94e-05	0.000363	CcSEcCtD
Disopyramide—Rash—Perindopril—coronary artery disease	9.88e-05	0.000361	CcSEcCtD
Disopyramide—Dermatitis—Perindopril—coronary artery disease	9.87e-05	0.00036	CcSEcCtD
Disopyramide—Nausea—Telmisartan—coronary artery disease	9.86e-05	0.00036	CcSEcCtD
Disopyramide—Fatigue—Lisinopril—coronary artery disease	9.85e-05	0.00036	CcSEcCtD
Disopyramide—Headache—Perindopril—coronary artery disease	9.82e-05	0.000358	CcSEcCtD
Disopyramide—Urticaria—Timolol—coronary artery disease	9.79e-05	0.000357	CcSEcCtD
Disopyramide—Pain—Lisinopril—coronary artery disease	9.77e-05	0.000357	CcSEcCtD
Disopyramide—Constipation—Lisinopril—coronary artery disease	9.77e-05	0.000357	CcSEcCtD
Disopyramide—Body temperature increased—Timolol—coronary artery disease	9.74e-05	0.000356	CcSEcCtD
Disopyramide—Dizziness—Losartan—coronary artery disease	9.72e-05	0.000355	CcSEcCtD
Disopyramide—Vomiting—Furosemide—coronary artery disease	9.69e-05	0.000354	CcSEcCtD
Disopyramide—Rash—Furosemide—coronary artery disease	9.61e-05	0.000351	CcSEcCtD
Disopyramide—Dermatitis—Furosemide—coronary artery disease	9.6e-05	0.00035	CcSEcCtD
Disopyramide—Nausea—Captopril—coronary artery disease	9.59e-05	0.00035	CcSEcCtD
Disopyramide—Headache—Furosemide—coronary artery disease	9.54e-05	0.000348	CcSEcCtD
Disopyramide—Feeling abnormal—Lisinopril—coronary artery disease	9.42e-05	0.000344	CcSEcCtD
Disopyramide—Vomiting—Losartan—coronary artery disease	9.35e-05	0.000341	CcSEcCtD
Disopyramide—Nausea—Perindopril—coronary artery disease	9.31e-05	0.00034	CcSEcCtD
Disopyramide—Rash—Losartan—coronary artery disease	9.27e-05	0.000338	CcSEcCtD
Disopyramide—Dermatitis—Losartan—coronary artery disease	9.26e-05	0.000338	CcSEcCtD
Disopyramide—Headache—Losartan—coronary artery disease	9.21e-05	0.000336	CcSEcCtD
Disopyramide—Urticaria—Lisinopril—coronary artery disease	9.08e-05	0.000332	CcSEcCtD
Disopyramide—Nausea—Furosemide—coronary artery disease	9.05e-05	0.00033	CcSEcCtD
Disopyramide—Asthenia—Ramipril—coronary artery disease	9.04e-05	0.00033	CcSEcCtD
Disopyramide—Body temperature increased—Lisinopril—coronary artery disease	9.04e-05	0.00033	CcSEcCtD
Disopyramide—Pruritus—Ramipril—coronary artery disease	8.92e-05	0.000326	CcSEcCtD
Disopyramide—Asthenia—Timolol—coronary artery disease	8.84e-05	0.000323	CcSEcCtD
Disopyramide—Nausea—Losartan—coronary artery disease	8.73e-05	0.000319	CcSEcCtD
Disopyramide—Pruritus—Timolol—coronary artery disease	8.72e-05	0.000318	CcSEcCtD
Disopyramide—Diarrhoea—Ramipril—coronary artery disease	8.62e-05	0.000315	CcSEcCtD
Disopyramide—Diarrhoea—Timolol—coronary artery disease	8.43e-05	0.000308	CcSEcCtD
Disopyramide—Dizziness—Ramipril—coronary artery disease	8.33e-05	0.000304	CcSEcCtD
Disopyramide—Asthenia—Lisinopril—coronary artery disease	8.2e-05	0.000299	CcSEcCtD
Disopyramide—Dizziness—Timolol—coronary artery disease	8.15e-05	0.000298	CcSEcCtD
Disopyramide—Pruritus—Lisinopril—coronary artery disease	8.09e-05	0.000295	CcSEcCtD
Disopyramide—Vomiting—Ramipril—coronary artery disease	8.01e-05	0.000293	CcSEcCtD
Disopyramide—Rash—Ramipril—coronary artery disease	7.95e-05	0.00029	CcSEcCtD
Disopyramide—Dermatitis—Ramipril—coronary artery disease	7.94e-05	0.00029	CcSEcCtD
Disopyramide—Headache—Ramipril—coronary artery disease	7.9e-05	0.000288	CcSEcCtD
Disopyramide—Vomiting—Timolol—coronary artery disease	7.83e-05	0.000286	CcSEcCtD
Disopyramide—Diarrhoea—Lisinopril—coronary artery disease	7.82e-05	0.000286	CcSEcCtD
Disopyramide—Rash—Timolol—coronary artery disease	7.77e-05	0.000284	CcSEcCtD
Disopyramide—Dermatitis—Timolol—coronary artery disease	7.76e-05	0.000283	CcSEcCtD
Disopyramide—Headache—Timolol—coronary artery disease	7.72e-05	0.000282	CcSEcCtD
Disopyramide—Dizziness—Lisinopril—coronary artery disease	7.56e-05	0.000276	CcSEcCtD
Disopyramide—Nausea—Ramipril—coronary artery disease	7.49e-05	0.000273	CcSEcCtD
Disopyramide—Nausea—Timolol—coronary artery disease	7.32e-05	0.000267	CcSEcCtD
Disopyramide—Vomiting—Lisinopril—coronary artery disease	7.27e-05	0.000265	CcSEcCtD
Disopyramide—Rash—Lisinopril—coronary artery disease	7.21e-05	0.000263	CcSEcCtD
Disopyramide—Dermatitis—Lisinopril—coronary artery disease	7.2e-05	0.000263	CcSEcCtD
Disopyramide—Headache—Lisinopril—coronary artery disease	7.16e-05	0.000261	CcSEcCtD
Disopyramide—Nausea—Lisinopril—coronary artery disease	6.79e-05	0.000248	CcSEcCtD
Disopyramide—CYP3A4—Metabolism—ARNTL—coronary artery disease	6.75e-06	5.34e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HADH—coronary artery disease	6.75e-06	5.34e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOB—coronary artery disease	6.65e-06	5.26e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOB—coronary artery disease	6.63e-06	5.25e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	6.59e-06	5.22e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	6.57e-06	5.2e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOB—coronary artery disease	6.57e-06	5.19e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	6.56e-06	5.19e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EDN1—coronary artery disease	6.55e-06	5.18e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	6.54e-06	5.17e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EDN1—coronary artery disease	6.53e-06	5.16e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	6.51e-06	5.15e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCL5—coronary artery disease	6.5e-06	5.14e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	6.48e-06	5.12e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AGT—coronary artery disease	6.48e-06	5.12e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL5—coronary artery disease	6.47e-06	5.12e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EDN1—coronary artery disease	6.46e-06	5.11e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARG—coronary artery disease	6.42e-06	5.08e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL5—coronary artery disease	6.41e-06	5.07e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOA2—coronary artery disease	6.4e-06	5.06e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	6.4e-06	5.06e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GPX2—coronary artery disease	6.4e-06	5.06e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CSF2—coronary artery disease	6.4e-06	5.06e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FGF1—coronary artery disease	6.4e-06	5.06e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FGF1—coronary artery disease	6.38e-06	5.05e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CSF2—coronary artery disease	6.38e-06	5.05e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LPL—coronary artery disease	6.35e-06	5.02e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOE—coronary artery disease	6.35e-06	5.02e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—POMC—coronary artery disease	6.33e-06	5.01e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LPL—coronary artery disease	6.33e-06	5.01e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SULT1A1—coronary artery disease	6.32e-06	5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCG5—coronary artery disease	6.32e-06	5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GPX4—coronary artery disease	6.32e-06	5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HK1—coronary artery disease	6.32e-06	5e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FGF1—coronary artery disease	6.32e-06	5e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CSF2—coronary artery disease	6.32e-06	5e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	6.29e-06	4.98e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	6.29e-06	4.98e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	6.27e-06	4.96e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	6.27e-06	4.96e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOA1—coronary artery disease	6.27e-06	4.96e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LPL—coronary artery disease	6.27e-06	4.96e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HADHA—coronary artery disease	6.25e-06	4.94e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	6.21e-06	4.92e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	6.21e-06	4.92e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTA1—coronary artery disease	6.17e-06	4.88e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	6.13e-06	4.85e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	6.11e-06	4.84e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LPA—coronary artery disease	6.11e-06	4.83e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	6.05e-06	4.79e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	5.99e-06	4.74e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARG—coronary artery disease	5.98e-06	4.73e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	5.97e-06	4.72e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	5.96e-06	4.71e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	5.94e-06	4.7e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLCB3—coronary artery disease	5.91e-06	4.68e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	5.91e-06	4.68e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—POMC—coronary artery disease	5.9e-06	4.67e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	5.88e-06	4.65e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOA5—coronary artery disease	5.85e-06	4.63e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	5.85e-06	4.63e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	5.83e-06	4.61e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	5.78e-06	4.57e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALB—coronary artery disease	5.77e-06	4.57e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—P4HB—coronary artery disease	5.74e-06	4.54e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	5.73e-06	4.53e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—C3—coronary artery disease	5.72e-06	4.52e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	5.71e-06	4.52e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—C3—coronary artery disease	5.7e-06	4.51e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	5.65e-06	4.47e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—C3—coronary artery disease	5.64e-06	4.47e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	5.63e-06	4.46e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARG—coronary artery disease	5.53e-06	4.37e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—NOS3—coronary artery disease	5.52e-06	4.37e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	5.45e-06	4.31e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—POMC—coronary artery disease	5.45e-06	4.31e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	5.44e-06	4.3e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AGT—coronary artery disease	5.43e-06	4.3e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AGT—coronary artery disease	5.42e-06	4.28e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	5.38e-06	4.26e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALB—coronary artery disease	5.38e-06	4.26e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AGT—coronary artery disease	5.36e-06	4.24e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOE—coronary artery disease	5.32e-06	4.21e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—LEP—coronary artery disease	5.32e-06	4.21e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—VCAN—coronary artery disease	5.31e-06	4.2e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—LEP—coronary artery disease	5.31e-06	4.2e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOE—coronary artery disease	5.31e-06	4.2e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDOA—coronary artery disease	5.27e-06	4.17e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOA1—coronary artery disease	5.26e-06	4.16e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOE—coronary artery disease	5.26e-06	4.16e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—LEP—coronary artery disease	5.26e-06	4.16e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOA1—coronary artery disease	5.25e-06	4.15e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KDR—coronary artery disease	5.22e-06	4.13e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KDR—coronary artery disease	5.2e-06	4.11e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOA1—coronary artery disease	5.19e-06	4.11e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	5.18e-06	4.1e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	5.16e-06	4.09e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KDR—coronary artery disease	5.15e-06	4.07e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NOS3—coronary artery disease	5.15e-06	4.07e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—DCN—coronary artery disease	5.12e-06	4.05e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	5.11e-06	4.05e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ESR1—coronary artery disease	5.08e-06	4.02e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ESR1—coronary artery disease	5.07e-06	4.01e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—coronary artery disease	5.05e-06	4e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—F2—coronary artery disease	5.02e-06	3.97e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FN1—coronary artery disease	5.02e-06	3.97e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ESR1—coronary artery disease	5.02e-06	3.97e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—F2—coronary artery disease	5e-06	3.96e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FN1—coronary artery disease	5e-06	3.96e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	5e-06	3.96e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	4.98e-06	3.94e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDH2—coronary artery disease	4.98e-06	3.94e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALB—coronary artery disease	4.97e-06	3.93e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	4.96e-06	3.92e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—F2—coronary artery disease	4.96e-06	3.92e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FN1—coronary artery disease	4.96e-06	3.92e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	4.95e-06	3.91e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	4.94e-06	3.9e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	4.9e-06	3.87e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HBA1—coronary artery disease	4.85e-06	3.84e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LIPC—coronary artery disease	4.85e-06	3.84e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	4.85e-06	3.84e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2C19—coronary artery disease	4.85e-06	3.84e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOC3—coronary artery disease	4.82e-06	3.81e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KIT—coronary artery disease	4.8e-06	3.8e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LDLR—coronary artery disease	4.79e-06	3.79e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KIT—coronary artery disease	4.79e-06	3.79e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NOS3—coronary artery disease	4.75e-06	3.76e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KIT—coronary artery disease	4.74e-06	3.75e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.73e-06	3.75e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.73e-06	3.75e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—coronary artery disease	4.71e-06	3.72e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GCLC—coronary artery disease	4.68e-06	3.7e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CETP—coronary artery disease	4.68e-06	3.7e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SDC1—coronary artery disease	4.63e-06	3.66e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	4.61e-06	3.65e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	4.6e-06	3.64e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—POMC—coronary artery disease	4.57e-06	3.62e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CREB1—coronary artery disease	4.57e-06	3.62e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—POMC—coronary artery disease	4.56e-06	3.61e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CREB1—coronary artery disease	4.56e-06	3.61e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	4.55e-06	3.6e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—POMC—coronary artery disease	4.51e-06	3.57e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CREB1—coronary artery disease	4.51e-06	3.57e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCL2—coronary artery disease	4.47e-06	3.54e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6R—coronary artery disease	4.46e-06	3.53e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL2—coronary artery disease	4.46e-06	3.53e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6R—coronary artery disease	4.45e-06	3.52e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL2—coronary artery disease	4.42e-06	3.49e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6R—coronary artery disease	4.4e-06	3.48e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IGF1—coronary artery disease	4.4e-06	3.48e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IGF1—coronary artery disease	4.39e-06	3.47e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	4.38e-06	3.46e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PSMB5—coronary artery disease	4.37e-06	3.46e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PSMA6—coronary artery disease	4.37e-06	3.46e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	4.36e-06	3.45e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—coronary artery disease	4.35e-06	3.44e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IGF1—coronary artery disease	4.34e-06	3.44e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	4.32e-06	3.42e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CTGF—coronary artery disease	4.27e-06	3.38e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMGCR—coronary artery disease	4.23e-06	3.35e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GOT2—coronary artery disease	4.23e-06	3.35e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	4.18e-06	3.31e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	4.18e-06	3.3e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	4.17e-06	3.3e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	4.16e-06	3.29e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	4.13e-06	3.27e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	4.12e-06	3.26e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FGF2—coronary artery disease	4.04e-06	3.2e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FGF2—coronary artery disease	4.03e-06	3.19e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FGF2—coronary artery disease	3.99e-06	3.16e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOS3—coronary artery disease	3.99e-06	3.16e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOS3—coronary artery disease	3.98e-06	3.15e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOS3—coronary artery disease	3.94e-06	3.11e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLCB1—coronary artery disease	3.89e-06	3.08e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—JAK2—coronary artery disease	3.88e-06	3.07e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—JAK2—coronary artery disease	3.86e-06	3.06e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—JAK2—coronary artery disease	3.83e-06	3.03e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	3.8e-06	3.01e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	3.79e-06	3e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.77e-06	2.98e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	3.75e-06	2.97e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GOT1—coronary artery disease	3.65e-06	2.89e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GGT1—coronary artery disease	3.65e-06	2.89e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	3.54e-06	2.8e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	3.53e-06	2.79e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	3.49e-06	2.76e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	3.42e-06	2.7e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	3.41e-06	2.7e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CASP3—coronary artery disease	3.39e-06	2.68e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CASP3—coronary artery disease	3.38e-06	2.67e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	3.37e-06	2.67e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6—coronary artery disease	3.36e-06	2.66e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6—coronary artery disease	3.35e-06	2.65e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CASP3—coronary artery disease	3.34e-06	2.64e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6—coronary artery disease	3.32e-06	2.63e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCND1—coronary artery disease	3.3e-06	2.61e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCND1—coronary artery disease	3.29e-06	2.6e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.28e-06	2.6e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCND1—coronary artery disease	3.25e-06	2.57e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.25e-06	2.57e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.24e-06	2.56e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—coronary artery disease	3.2e-06	2.53e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CAT—coronary artery disease	3.19e-06	2.53e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—coronary artery disease	3.19e-06	2.52e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—coronary artery disease	3.16e-06	2.5e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CA—coronary artery disease	3.11e-06	2.46e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	3.1e-06	2.46e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOB—coronary artery disease	3.1e-06	2.45e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	3.09e-06	2.45e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	3.06e-06	2.42e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.02e-06	2.39e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—LPL—coronary artery disease	2.96e-06	2.34e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CA—coronary artery disease	2.9e-06	2.29e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GPX1—coronary artery disease	2.89e-06	2.28e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	2.87e-06	2.27e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	2.86e-06	2.27e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	2.84e-06	2.24e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CD36—coronary artery disease	2.81e-06	2.22e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.78e-06	2.2e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CA—coronary artery disease	2.68e-06	2.12e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.66e-06	2.11e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	2.64e-06	2.09e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	2.63e-06	2.08e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	2.6e-06	2.06e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	2.59e-06	2.05e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	2.58e-06	2.04e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	2.55e-06	2.02e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKT1—coronary artery disease	2.54e-06	2.01e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AGT—coronary artery disease	2.53e-06	2e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOE—coronary artery disease	2.48e-06	1.96e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOA1—coronary artery disease	2.45e-06	1.94e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKT1—coronary artery disease	2.37e-06	1.87e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	2.24e-06	1.78e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	2.24e-06	1.77e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	2.22e-06	1.75e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKT1—coronary artery disease	2.19e-06	1.73e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARG—coronary artery disease	2.16e-06	1.71e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—POMC—coronary artery disease	2.13e-06	1.69e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6—coronary artery disease	1.99e-06	1.57e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6—coronary artery disease	1.98e-06	1.57e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6—coronary artery disease	1.96e-06	1.55e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALB—coronary artery disease	1.94e-06	1.54e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NOS3—coronary artery disease	1.86e-06	1.47e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1.83e-06	1.45e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT1—coronary artery disease	1.83e-06	1.45e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT1—coronary artery disease	1.81e-06	1.43e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.7e-06	1.34e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.05e-06	8.27e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKT1—coronary artery disease	8.54e-07	6.76e-06	CbGpPWpGaD
